Chief Manufacturing & Technology Officer 2022-
Orizuru Therapeutics, Inc.
Business Head 2021-
iPSC-derived Pancreatic Islet Cell (iPIC) Therapy, Orizuru Therapeutics, Inc.
- One of the founding members of biotech venture, Orizuru
- Currently responsible for developing business plan of iPIC therapy
Associate director 2015-2021
T-CiRA* joint program, Takeda Pharmaceutical Company Limited
- Led iPIC research as a co-principal investigator of Takeda in collaboration with Dr. Toyoda, a principal investigator of CiRA
- Acquired 2.7 oku yen public funding (AMED) based on the research results
* Takeda and CiRA, Center for iPS Cell Research and Application, Kyoto University
Principal Scientist 2011-2015
Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Limited
- >10-year of research experience in diabetes fields
- Involved in drug discovery research to New Drug Application of several anti-diabetes drugs including NESINA
Takeda Pharmaceutical Company Limited